| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000203496.4 |
Ponatinib |
Pancreatic adenocarcinoma |
0.032573191 |
Resistant |
| ENSG00000203496.4 |
Ponatinib |
Skin cutaneous melanoma |
0.020872747 |
Resistant |
| ENSG00000203496.4 |
Ponatinib |
Breast invasive carcinoma |
0.041633287 |
Resistant |
